About Lung Biotechnology
Lung Biotechnology is a Healthcare company based in Silver Spring (United States) founded in 2006. It offers biotechnology solutions for managing pulmonary arterial hypertension and supporting lung transplants. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Pulmonary Diseases. Similar companies include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed similar companies have raised funding.
Company details
Lung Biotechnology, based in Silver Spring, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and pulmonary diseases. Offers biotechnology solutions for managing pulmonary arterial hypertension and supporting lung transplants. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Silver Spring, United States
- SectorsHealthcare
- Website lungbiotechnology.com
- Social Facebook
People of Lung Biotechnology
3 people are tracked at Lung Biotechnology (3 in leadership).
| Name | Role | Group |
|---|---|---|
Aimee Smart | VP, Clinical Development & Regulatory Processes | Leadership |
Martine Rothblatt | Chairman & CEO | Leadership |
Marc I. Lorber | Chief Medical Officer & SVP, Clinical Development & XenoLung | Leadership |
Complete people profiles for Lung Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Lung Biotechnology
Lung Biotechnology has 3 listed similar companies in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed similar companies of Lung Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Lung Biotechnology (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lung Biotechnology
Complete news archive for Lung Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lung Biotechnology
Lung Biotechnology was founded in 2006.
Lung Biotechnology is headquartered in Silver Spring, United States. It is registered at Silver Spring, Maryland, United States.
Lung Biotechnology, based in Silver Spring, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and pulmonary diseases. Offers biotechnology solutions for managing pulmonary arterial hypertension and supporting lung transplants. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Lung Biotechnology's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.